# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 81-90 of 2723 results.
A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer
Status: Withdrawn
Last Changed: Oct 18, 2019
First Received: Sep 13, 2017
Disease(s): Ovarian Cancer
Intervention(s): VAL-083, Dianhydrogalactitol
Locations: St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Henry Ford Hospital, Detroit, Michigan, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
Role of Surgery in Advanced Ovarian Cancer
Status: Completed
Last Changed: Jun 10, 2019
First Received: Jun 10, 2019
Disease(s): Ovarian Cancer
Locations: Institut Claudius Regaud - IUCT-Oncopole, Toulouse, Occitanie, France
Mesenchymal Stem Cells (MSC) for Ovarian Cancer
Status: Completed
Last Changed: Jul 18, 2019
First Received: Aug 20, 2015
Disease(s): Ovarian Cancer
Intervention(s): MSC-INFβ, Questionnaires
Locations: University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer
Status: Unknown status
Last Changed: Aug 21, 2018
First Received: Feb 12, 2016
Disease(s): Epithelial Ovarian Cancer
Intervention(s): HIPEC, No HIPEC
Locations: Hospital General Ciudad Real, Ciudad Real, Spain
Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy
Status: Recruiting
Last Changed: Dec 05, 2019
First Received: Nov 14, 2019
Disease(s): Ovarian Cancer
Intervention(s): W_ova1 Vaccine
Locations: UMCG, Groningen, Netherlands
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
Status: Completed
Last Changed: Feb 25, 2015
First Received: Aug 31, 2004
Disease(s): Ovarian Cancer
Intervention(s): Docetaxel, Carboplatin
Locations: Florida Gynecologic Oncology, Fort Myers, Florida, United States
Jupiter Medical Center-Gynecology Oncology and Gynecology, Jupiter, Florida, United States
Florida Hospital/Gyn/Onc Department, Orlando, Florida, United States
Hematology-Onc. Assoc. of The Quad Cities, Bettendorf, Iowa, United States
University of Iowa, Iowa City, Iowa, United States
... and 15 other locations.
Risk of Ovarian Cancer in Patients With a Pelvic Mass
Status: Completed
Last Changed: Nov 08, 2011
First Received: Apr 19, 2006
Disease(s): Ovarian Cancer
Intervention(s): Biomarker Assay (CA125 and HE4)
Locations: Fujirebio Diagnostics, Inc, Malvern, Pennsylvania, United States
Richard Moore, Providence, Rhode Island, United States
Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer
Status: Active, not recruiting
Last Changed: Jan 18, 2020
First Received: Dec 06, 2017
Disease(s): Ovarian Cancer
Intervention(s): Fitness Tracker, Social Incentive (Way to Health)
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer
Status: Not yet recruiting
Last Changed: Aug 10, 2020
First Received: Nov 04, 2019
Disease(s): Ovarian Cancer Recurrent
Intervention(s): M4344+Niraparib, M4344+Niraparib
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
Factors Affecting the Prognosis of Early Ovarian Cancer
Status: Recruiting
Last Changed: Jun 04, 2020
First Received: Jun 04, 2020
Disease(s): Ovarian Cancer
Intervention(s): staging surgery
Locations: Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital, Banqiao, New Taipei, Taiwan